TARS · CIK 0001819790 · operating
Tarsus Pharmaceuticals, Inc. (TARS) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $3.3 billion, Tarsus Pharmaceuticals, Inc. is a mid-cap company. The stock currently trades at $77.43, up 2.53% today, with a 52-week range of $38.51–$85.25. The company trades at a forward P/E of 26.9x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-1.59 | $-1.59 | +48.2% | |
| 2024 | $-3.07 | $-3.07 | +33.5% | |
| 2023 | $-4.62 | $-4.62 | -83.3% | |
| 2022 | $-2.52 | $-2.52 | -276.1% | |
| 2021 | $-0.67 | $-0.67 | — | |
| 2020 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-23 | 0001819790-26-000019 | SEC ↗ |
| 2024-12-31 | 2025-02-25 | 0001819790-25-000011 | SEC ↗ |
| 2023-12-31 | 2024-02-27 | 0001819790-24-000018 | SEC ↗ |
| 2022-12-31 | 2023-03-17 | 0001819790-23-000007 | SEC ↗ |
| 2021-12-31 | 2022-03-14 | 0001819790-22-000010 | SEC ↗ |
| 2020-12-31 | 2021-03-31 | 0001819790-21-000010 | SEC ↗ |